Pharmacological treatment during rehabilitation. New drugs and a new concepts;Farmacoterapia de la deshabituación alcohólica. Nuevos fármacos, nuevos conceptos

Adicciones

Volumn 14, Issue SUPPL. 1, 2002, Pages 439-448

  Balcells, M ^a   Gual, Antoni ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

hidroxibutiric acid; Acamprosate; Alcohol; Bromocriptin; Buspirone; Craving; Dependence; Disulfiram; Flupenthixol; Nalmefene; Naltrexone; Ondansetron; SSRI; Tiapride

Indexed keywords

4 AMINOBUTYRIC ACID; 4 HYDROXYBUTYRIC ACID; ACAMPROSATE; BROMOCRIPTINE; BUSPIRONE; DISULFIRAM; DOPAMINE; FLUPENTIXOL; GLUTAMIC ACID; NALTREXONE; ONDANSETRON; OPIATE RECEPTOR; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; TIAPRIDE;

ALCOHOLISM; DOPAMINERGIC SYSTEM; DRUG MECHANISM; GABAERGIC SYSTEM; HUMAN; REVIEW; REWARD; SEROTONINERGIC SYSTEM;

EID: 0036195717     PISSN: 02144840     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. The neural basis of drug craving: An incentive-sensitization theory of addiction
2. The efficacy of disulfiram; a review of outcome studies
3. Alcoholism treatment by disulfiram and community reinforcement therapy
4. Naltrexona mas aversivo en alcoholicos refractarios a tratamiento
5. Disulfiram treatment of alcoholism
6. Disulfiram implantation: A placebo-controlled trial with two-year follow-up
7. Disulfiram implantation: A trial using placebo implants and two types of controls
8. Disulfiram treatment of alcoholism: A Veterans Administration cooperative study
9. Pharmacological trials in alcoholics: Some comments on methodological problems
10. The neurobiology of alcohol abuse
11. Maintaining abstinence from alcohol with γ-hidroxibutyric acid
12. g-hidroxibutyric acid in the treatment of alcohol dependence: A double blind study
13. g-hidroxibutyric acid in the treatment of alcohol dependence: Possible craving development for the drug
14. Poisoning with gamma-hydroxybutyrate. Cases reported in connection with "cultural festivals" in August 1999 in Kolding
15. Successful management of prolonged gamma-hydroxybutyrate and alcohol withdrawal
16. Gamma-hydroxybutyric acid and alcohol-related syndromes
17. Acamprosate in alcohol dependence; how does it work?
18. Premier essai favorable du bis acetylhomotaurinate de calcium (AOTA Ca) dans le traitement de l'alcoolodependant
19. New drug treatment for alcohol problems: A critical appraisal
20. Relapse prevention in alcoholism. Recent advances and future possibilities
21. Acamprosate versus placebo in the long term treatment of patients with dependence
22. Acamprosate in clinical practice: The french experience
23. Naltrexone in the treatment of alcoholism. Clinical evolution, safety and efficacy in a sample of 198 patients
24. The alcohol prefering C57B1/6 mice present an enhanced sensitivity of the hypothalamic b-endorphin system to ethanol than the alcohol avoiding DBA/2 mice
25. Differences in the brain and pituitary b-endorphin system between the alcohol preferent AA and alcohol avoiding ANA rats
26. Central deficiency of b-endorfine in alcohol addicts
27. Implication of the endogenous opioid system in excessive ethanol consumption
28. Neurobehavioral aspects of pharmacotherapy of alcohol dependence
29. Effects of naltrexone on amphetamine-induced locomotion and rearing: Acute and repeated injection
30. Naltrexone in the treatment of alcohol dependence
31. Naltrexone and coping skills therapy for alcohol dependence
32. A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol-dependence disorder. Results from a multicenter clinical trial
33. Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: Results of a placebo-controlled trial
34. Acamprosate during and after acute alcohol withdrawal: A double-blind placebo-controlled study in Spain
35. Naltrexone versus acamprosate: One year follow-up of alcohol dependence treatment
36. UK multicentre study of naltrexone as adjuntive therapy in the treatment of alcoholism: Efficacy results
37. Naltrexonein the treatment of alcohol dependence
38. Posttreatment results of combining naltrexone with cognitive-behavior therapy for the treatment of alcoholism
39. Naltrexone vs. nefazodone for treatment of alcohol dependence. A placebo-controlled trial
40. A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse
41. Cnaan A Double-blind clinical trial of sertraline treatment for alcohol dependence
42. Sustained-release naltrexone for alcoholism treatment: A preliminary study
43. Nalmefene modification of alcohol dependence
44. Long-acting injectable bromocriptine do not reduce relapse in alcoholics
45. 2 dopamine receptor allele
46. Tiapride in the prevention of relapse in recently detoxified alcoholics
47. Six-month open trial with zimelidine in alcohol-dependent patients: Reduction in days of alcohol intake
48. Flupenthixol decanoate and relapse prevention in alcoholics: Results from a placebo-controlled study
49. Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers
50. Fluoxetine trial in suicidal depressed alcoholics
51. Fluoxetine in depressed alcoholics. A double-blind, placebo-controlled trial
52. Fluoxetine treatment seems to reduce the beneficial effects of cognitive-behavioral therapy in type B alcoholics
53. Citalopram in the treatment of alcoholism: A double-blind placebo-controlled study
54. Placebo-controlled study of sertraline in depressed recently abstinent alcoholics
55. Buspirone treatment of anxious alcoholics: A placebo-controlled trial
56. Efficacy of buspirone in alcohol dependence: A review
57. Buspirone treatment of alcoholism: Age of onset, and cerebrospinal fluid 5-hydroxyindolacetic acid and homovanillic acid concentrations, but not medication treatment, predict return to drinking
58. Combining ondansetron and naltrexone effectively treats biologically predisposed alcoholics: From hypotheses to preliminary clinical evidence
59. Combining ondansetron and naltrexone reduces craving among biologically predisposed alcoholics: Preliminary clinical evidence
60. Effect of acamprosate and naltrexone, alone or in combination, on ethanol consumption